Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A tube of Clascoterone 5% topical solution in a clinical trial room

Jul 23, 2026

Cosmo Reports Double-Digit Recurring Revenue Growth in H1 2026, Advances Clascoterone 5% Topical Solution Toward Regulatory Submission, and Confirms Full-Year Guidance

Cosmo N.V. has reported significant growth in recurring revenues for the first half of 2026, driven by strong performances from its key products and advancements in its clinical pipeline.The company achieved a notable 38% increase in revenue from Winlevi® and a 35% rise from Lialda®, alongside a 14% growth in its Contract Development and Manufacturing Organization (CDMO) segment. This growth underscores the strength and diversification of Cosmo's business model. Furthermore, the Phase III clinic
cloud and 3D model silhouette

Jul 23, 2026

Dassault Systèmes: Solid Q2 results and confirming

Dassault Systèmes has reported strong second-quarter results for 2026, reaffirming its full-year objectives while expanding its footprint in the Life Sciences sector through the acquisition of ArisGlobal.The company achieved a 4% increase in total revenue during Q2 2026, largely attributed to an 8% rise in subscription services. Notably, both 3D EXPERIENCE and cloud software revenues experienced a 14% boost, primarily driven by demand in the manufacturing industries. The annual run rate also ref
A clipboard with a patient chart in a hospital corridor

Jul 23, 2026

U.S. Payer Friction, Canada Data Fragmentation and U.K. Pathway Delays Expose Same Digital Health Completion Gap

A recent Black Book survey reveals significant challenges in clinical workflow completion across the U.S., Canada, and the U.K., despite advancements in digital health technologies.The survey, which included responses from 2,040 clinicians, highlights that while electronic health records (EHRs), artificial intelligence (AI), and interoperability are progressing, the actual completion of clinical tasks often requires manual follow-up. The study assessed the Clinical Loop Closure Index, which scor
Flat illustration of a tissue sample and AI tool

Jul 23, 2026

Why the AI-native advantage in life sciences isn’t coming from replacing humans

The article discusses the transformative potential of AI in the life sciences sector, emphasizing that the true advantage comes not from replacing human roles but from enhancing operational efficiencies through carefully integrated AI tools.While the healthcare industry has been slower to adopt AI compared to other sectors, it has seen significant successes in specialized applications, such as cancer detection and drug discovery. However, these advancements have typically been limited to specifi
A minimalist illustration of a neuron representing bio-intelligence in a digital landscape.

Jul 22, 2026

MindWalk Holdings Corp. Reports Fiscal 2026 Results: Revenue Up 46% as the Company Completes Its Pivot to Bio-Native AI Infrastructure

MindWalk Holdings Corp. has reported a significant 46% revenue increase for fiscal 2026, marking a pivotal year in its transition toward Bio-Native AI infrastructure.The company, which has shifted its focus from technology development to deployment, achieved notable financial results with a gross margin expansion and a reduction in net loss. This year was characterized by strategic divestments, including the sale of a non-core business, allowing MindWalk to concentrate on its BioIntelligence pla
A stack of credentialing documents on a wooden desk in an office setting.

Jul 22, 2026

Assured Raises $19M to Replace Manual Credentialing with Autonomous AI Agents -

Assured, a provider operations platform, has successfully secured $19 million in Series A funding, aiming to revolutionize healthcare credentialing through autonomous AI agents.Led by Insight Partners, with contributions from First Round Capital and Kindred Ventures, this funding will enhance Assured's capabilities to streamline the labor-intensive process of provider credentialing and payer enrollment. Currently serving over 100 healthcare organizations, including major health systems and digit
A glass vial containing a drug compound on a lab bench with equipment in the background.

Jul 22, 2026

Cheiron Raises $8M to Launch AI-Native the Operating System for Drug Programs

Cheiron, an AI-native platform in the life sciences sector, has successfully raised $8 million in seed funding, with notable investors including Menlo Ventures and high-profile figures from the biotech and tech industries.The platform aims to transform the fragmented landscape of drug development by consolidating various data sources—such as clinical, regulatory, and commercial information—into a single, auditable operating system. This interconnected approach is designed to streamline the drug
An open book and a brain silhouette representing content and AI.

Jul 22, 2026

Reddit (NYSE:RDDT) Shares Drop Amid Reports Of Google AI Licensing Dispute And Traffic Fears

Reddit's recent stock decline is attributed to a reported licensing dispute with Google, raising alarms about the platform's traffic and revenue forecasts.The crux of the issue lies in Reddit's extensive content library, which Google allegedly uses to train its AI models. Disagreements over the terms of this arrangement have led to heightened tensions, as Reddit has previously engaged in data licensing deals with AI firms, leveraging its user-generated content as a critical resource for training
A syringe on a lab bench in a dimly lit laboratory

Jul 22, 2026

Dimension Raises $800 Million for Third Fund Focused on AI and Biotechnology

Dimension, a venture capital firm, has successfully raised $800 million for its third fund, aimed at supporting startups that blend technology with biotechnology.The newly acquired capital will enhance Dimension's existing portfolio, which already comprises 35 companies leveraging artificial intelligence within the life sciences sector. The firm emphasizes the significant growth potential at the intersection of these two fields, indicating a strategic focus on investments that drive innovation i
A minimalist illustration of a syringe and drug vial representing a legal dispute in pharmaceuticals.

Jul 22, 2026

Novo Nordisk Files Lawsuit Against Eli Lilly | PharmExec

In a significant legal development, Novo Nordisk has initiated a lawsuit against Eli Lilly, claiming misleading advertising practices regarding their GLP-1 drugs.Novo Nordisk's lawsuit targets Eli Lilly's promotional materials for Zepbound and Mounjaro, asserting that these ads unfairly compare their products to outdated doses of Wegovy and Ozempic. Specifically, the complaint highlights that ads for Zepbound utilize lower doses of Wegovy—1.7 and 2.4 milligrams—while neglecting the recently appr
Interlocking gears representing collaboration in AI readiness

Jul 22, 2026

Building AI Readiness Through Cross Collaboration

The integration of artificial intelligence (AI) in pharmaceutical operations presents significant opportunities, but practical implementation remains a challenge. Michael Grischeau and Paula Gamboa from AbbVie emphasize the importance of cross-functional collaboration to bridge the gap between AI potential and readiness.During a recent discussion at the ISPE AI in Life Science Summit, Grischeau and Gamboa outlined AbbVie’s Operations Quality Assurance Innovation Accelerator. This initiative aims
Hollow microneedles and syringe in a clinical setting

Jul 22, 2026

Trinity Biotech inks partnership to pair CGM+ with drug delivery system

Trinity Biotech has announced a strategic partnership with Latch Medical to integrate its CGM+ wearable biosensor with Latch's intradermal drug delivery technology.The collaboration aims to leverage Latch Medical's Pharma Latch platform, which utilizes hollow microneedles for precise and reliable drug administration. This innovative technology is designed for both clinical and home use, allowing for the delivery of various injectable therapies. The partnership seeks to develop tailored therapeut